mevalonolactone has been researched along with Muscle Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birk, OS; Davidov, G; Dolgin, V; Drabkin, M; Hadar, N; Halperin, D; Koifman, A; Nudelman, H; Perez, Y; Proskorovski-Ohayon, R; Shelef, I; Shorer, Z; Wormser, O; Yogev, Y; Zarivach, R | 1 |
| Anayama, H; Hamajyo, H; Hirakata, M; Ishikawa, E; Nagai, H; Nishimoto, T; Tozawa, R | 1 |
2 other study(ies) available for mevalonolactone and Muscle Disorders
| Article | Year |
|---|---|
Limb girdle muscular disease caused by
Topics: Animals; Autoantibodies; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Muscular Diseases; Mutation | 2023 |
Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
Topics: Animals; Biomarkers; Cholesterol; Creatine Kinase; Drug Antagonism; Drug Therapy, Combination; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Guinea Pigs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Muscle, Skeletal; Muscular Diseases; Oxazepines; Piperidines; Pyridines | 2007 |